PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.78%
Revenue growth at 75-90% of ADI's 7.09%. Bill Ackman would push for innovation or market expansion to catch up.
1.19%
Gross profit growth under 50% of ADI's 7.57%. Michael Burry would be concerned about a severe competitive disadvantage.
8.44%
EBIT growth 50-75% of ADI's 13.87%. Martin Whitman would suspect suboptimal resource allocation.
8.44%
Operating income growth at 50-75% of ADI's 13.87%. Martin Whitman would doubt the firm’s ability to compete efficiently.
3.96%
Net income growth under 50% of ADI's 10.80%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.56%
EPS growth at 50-75% of ADI's 11.11%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
5.56%
Diluted EPS growth at 50-75% of ADI's 11.11%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.59%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.84%
Slight or no buyback while ADI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
38.32%
Dividend growth of 38.32% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
30.10%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
26.88%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
129.53%
10Y revenue/share CAGR at 50-75% of ADI's 239.58%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
77.01%
5Y revenue/share CAGR at 50-75% of ADI's 149.16%. Martin Whitman would worry about a lagging mid-term growth trajectory.
44.21%
3Y revenue/share CAGR under 50% of ADI's 100.40%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
2867.62%
5Y OCF/share CAGR above 1.5x ADI's 56.85%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
31.90%
3Y OCF/share CAGR under 50% of ADI's 341.67%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
378.63%
10Y net income/share CAGR of 378.63% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
3684.73%
5Y net income/share CAGR above 1.5x ADI's 646.70%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
303.89%
Below 50% of ADI's 646.70%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
37.08%
Below 50% of ADI's 105.42%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
53.77%
3Y equity/share CAGR at 50-75% of ADI's 98.05%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
20.80%
Dividend/share CAGR of 20.80% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
10.83%
3Y dividend/share CAGR of 10.83% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
13.60%
AR growth well above ADI's 4.15%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.04%
Inventory growth well above ADI's 0.89%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.58%
Asset growth above 1.5x ADI's 4.04%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.55%
Under 50% of ADI's 137.42%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
4.60%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.79%
R&D growth drastically higher vs. ADI's 5.11%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-5.72%
We cut SG&A while ADI invests at 3.95%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.